ICU Medical (NASDAQ:ICUI) Shares Gap Up – Still a Buy?

ICU Medical, Inc. (NASDAQ:ICUI)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $160.11, but opened at $167.49. ICU Medical shares last traded at $167.40, with a volume of 20,959 shares changing hands.

Analyst Ratings Changes

A number of analysts have weighed in on ICUI shares. KeyCorp increased their target price on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday. Raymond James upped their target price on shares of ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $177.25.

ICU Medical Stock Performance

The stock’s 50 day moving average price is $171.48 and its 200-day moving average price is $150.56. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Insider Buying and Selling at ICU Medical

In related news, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $18,665,666.78. The trade was a 10.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 40,364 shares of company stock valued at $6,869,878. 6.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Innealta Capital LLC acquired a new stake in ICU Medical in the second quarter worth about $32,000. Hexagon Capital Partners LLC boosted its stake in ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares in the last quarter. Allworth Financial LP boosted its stake in ICU Medical by 100.0% in the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Venturi Wealth Management LLC grew its position in ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in ICU Medical during the 2nd quarter valued at approximately $70,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.